Status:
COMPLETED
Breath Analysis as an Additional Test for Colorectal Cancer Screening to Reduce the Number of Unnecessary Colonoscopies
Lead Sponsor:
Radboud University Medical Center
Conditions:
Colorectal Cancer
Polyp of Colon
Eligibility:
All Genders
50-75 years
Phase:
NA
Brief Summary
In the past decade, the demand for colonoscopy procedures has increased significantly since the introduction of population-based colorectal cancer (CRC) screening in many western countries. Post-polyp...
Detailed Description
Rationale: An electronic nose (eNose) is an artificial olfactory system that analyses volate organic compounds (VOCs) in exhaled breath. Exhaled human breath is mainly composed of inorganic compounds,...
Eligibility Criteria
Inclusion
- Adult patients between the ages of 55 and 75 years referred for a colonoscopy procedure after a positive FIT test, according to the population based CRC screening program in the Netherlands
Exclusion
- Prior surgical resection of any portion of the colon
- History of any type of malignancy, not including squamous cell carcinoma (SCC) and basal cell carcinoma (BCC)
- Current active colitis or history of polyposis syndrome
Key Trial Info
Start Date :
May 25 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 5 2022
Estimated Enrollment :
750 Patients enrolled
Trial Details
Trial ID
NCT04357158
Start Date
May 25 2020
End Date
July 5 2022
Last Update
November 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Radboud university medical center
Nijmegen, Gelderland, Netherlands, 6525GA